Plasma Mitochondrial DNA--a Novel DAMP in Pediatric Sepsis

Valentina Di Caro1, Thomas D Walko, R Aaron Bola

  • 1*Department of Critical Care Medicine, University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania †University at Buffalo, State University of New York at Buffalo, Buffalo, New York ‡Department of Chemistry, Carnegie Mellon University §Departments of Critical Care Medicine and Pediatrics, University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh, Pittsburgh ||Department of Pediatrics, Division of Pediatric Critical Care Medicine, Penn State Hershey Children's Hospital, Pennsylvania State University College of Medicine, Hershey, Pennsylvania.

Shock (Augusta, Ga.)
|December 20, 2015
PubMed

Insights

Elevated mitochondrial DNA (mtDNA) levels in septic children indicate a novel danger signal. Higher mtDNA concentrations correlate with increased illness severity and organ failure in pediatric sepsis.

Area of Science:

  • Immunology
  • Molecular Biology
  • Pediatric Critical Care

Background:

  • Mitochondrial DNA (mtDNA) functions as a danger-associated molecular pattern.
  • Extracellular mtDNA signals through toll-like receptor-9 (TLR9), a key immune system receptor.
  • Sepsis involves a dysregulated immune response, with potential roles for danger signals like mtDNA.

Purpose of the Study:

  • To investigate if plasma mtDNA concentrations are elevated in children with sepsis.
  • To determine the association between plasma mtDNA levels and sepsis severity, including organ failure.
  • To examine the in vitro effect of mtDNA on immune cell activation and pro-inflammatory cytokine release.

Main Methods:

  • Plasma samples from pediatric patients with sepsis/systemic inflammatory response syndrome and control groups were analyzed.
  • Mitochondrial gene cytochrome c oxidase 1 (COX1) concentrations were quantified using real-time quantitative PCR.
  • Peripheral blood mononuclear cells (PBMCs) were exposed to mtDNA in vitro, and supernatant tumor necrosis factor (TNF) levels were measured.

Main Results:

  • Septic children exhibited significantly higher plasma mtDNA concentrations compared to critically ill non-septic and healthy controls.
  • Plasma mtDNA levels were markedly elevated in patients with multiple organ failure (MOF) versus those without MOF.
  • In vitro, mtDNA exposure led to increased TNF release from PBMCs, suggesting immune activation.

Conclusions:

  • Plasma mtDNA serves as a novel danger-associated molecular pattern in pediatric sepsis.
  • Elevated plasma mtDNA concentrations are associated with increased illness severity and MOF in pediatric sepsis.
  • mtDNA can activate immune cells, contributing to the inflammatory response observed in sepsis.